A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province

Hadron therapy (HT) with protons and carbon ions is an advanced radiotherapy technique. As the first report addressing this topic, the present study aimed to estimate the number of patients eligible for HT in Fars province and the whole of Iran. The data were collected through direct inspection of m...

Full description

Bibliographic Details
Main Authors: Mohammad Amin Hosseini, Mohammad Mohamadianpanah, Mohammad Zare-Bandeamiri, Mohammad Amin Mosleh-Shirazi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2018-05-01
Series:Iranian Journal of Medical Sciences
Subjects:
Online Access:http://ijms.sums.ac.ir/index.php/IJMS/article/view/4108
_version_ 1818291128475058176
author Mohammad Amin Hosseini
Mohammad Mohamadianpanah
Mohammad Zare-Bandeamiri
Mohammad Amin Mosleh-Shirazi
author_facet Mohammad Amin Hosseini
Mohammad Mohamadianpanah
Mohammad Zare-Bandeamiri
Mohammad Amin Mosleh-Shirazi
author_sort Mohammad Amin Hosseini
collection DOAJ
description Hadron therapy (HT) with protons and carbon ions is an advanced radiotherapy technique. As the first report addressing this topic, the present study aimed to estimate the number of patients eligible for HT in Fars province and the whole of Iran. The data were collected through direct inspection of medical records of the patients treated at the Radiotherapy Department, Namazi Hospital, Shiraz, Iran in 2014. The patients who were treated with external-beam radiotherapy and declared to be a resident of Fars province were extracted from the medical records. After classification based on appropriate indications and factors, the number of eligible patients in Iran was calculated by scaling (Iran: Fars population). Of the 2,932 medical records, 1,943 patients were treated with external-beam radiotherapy, among which 1,536 were from Fars. The total number of patients eligible for HT in Fars was >351 cases/year (22.9% of the treated patients). The cancer site distribution of the eligible Fars residents was central nervous system primary tumors (n=31), brain metastases (n=64), eye (n=7), head and neck (n=28); thyroid (n=4), lung (n=17), breast (n=56), esophagus (n=5); pancreas (n=5), gastric (n=32), liver and bile duct (n=0), rectum and anus (n=26); prostate (n=27), bladder (n=8), cervix (n=6), soft tissue (n=17); kidney (n=1), Hodgkin lymphoma (n=9), non-Hodgkin lymphoma (n=4), and bone metastases (n=4). A total number of 5,756 cases/year was estimated for the entire country. Considering the experiences of other countries, these results suggest that establishing at least two HT centers (covering the northern and southern parts of Iran) is justified based on the total number of patients. Further accurate estimations and cost evaluations are recommended.
first_indexed 2024-12-13T02:39:08Z
format Article
id doaj.art-579adf46d1d346ba916040a7d95f05c4
institution Directory Open Access Journal
issn 0253-0716
1735-3688
language English
last_indexed 2024-12-13T02:39:08Z
publishDate 2018-05-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Medical Sciences
spelling doaj.art-579adf46d1d346ba916040a7d95f05c42022-12-22T00:02:20ZengShiraz University of Medical SciencesIranian Journal of Medical Sciences0253-07161735-36882018-05-01433313317A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars ProvinceMohammad Amin Hosseini0Mohammad Mohamadianpanah1Mohammad Zare-Bandeamiri2Mohammad Amin Mosleh-Shirazi3Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, IranColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; and Department of Radiotherapy and Oncology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, IranDepartment of Radiotherapy and Oncology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, IranIonizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran; and Department of Radiotherapy and Oncology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, IranHadron therapy (HT) with protons and carbon ions is an advanced radiotherapy technique. As the first report addressing this topic, the present study aimed to estimate the number of patients eligible for HT in Fars province and the whole of Iran. The data were collected through direct inspection of medical records of the patients treated at the Radiotherapy Department, Namazi Hospital, Shiraz, Iran in 2014. The patients who were treated with external-beam radiotherapy and declared to be a resident of Fars province were extracted from the medical records. After classification based on appropriate indications and factors, the number of eligible patients in Iran was calculated by scaling (Iran: Fars population). Of the 2,932 medical records, 1,943 patients were treated with external-beam radiotherapy, among which 1,536 were from Fars. The total number of patients eligible for HT in Fars was >351 cases/year (22.9% of the treated patients). The cancer site distribution of the eligible Fars residents was central nervous system primary tumors (n=31), brain metastases (n=64), eye (n=7), head and neck (n=28); thyroid (n=4), lung (n=17), breast (n=56), esophagus (n=5); pancreas (n=5), gastric (n=32), liver and bile duct (n=0), rectum and anus (n=26); prostate (n=27), bladder (n=8), cervix (n=6), soft tissue (n=17); kidney (n=1), Hodgkin lymphoma (n=9), non-Hodgkin lymphoma (n=4), and bone metastases (n=4). A total number of 5,756 cases/year was estimated for the entire country. Considering the experiences of other countries, these results suggest that establishing at least two HT centers (covering the northern and southern parts of Iran) is justified based on the total number of patients. Further accurate estimations and cost evaluations are recommended.http://ijms.sums.ac.ir/index.php/IJMS/article/view/4108Proton therapyCarbon ion radiotherapyPatient selectionTreatment costsHospitals
spellingShingle Mohammad Amin Hosseini
Mohammad Mohamadianpanah
Mohammad Zare-Bandeamiri
Mohammad Amin Mosleh-Shirazi
A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province
Iranian Journal of Medical Sciences
Proton therapy
Carbon ion radiotherapy
Patient selection
Treatment costs
Hospitals
title A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province
title_full A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province
title_fullStr A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province
title_full_unstemmed A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province
title_short A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province
title_sort preliminary study on the estimation of the number of cancer patients eligible for hadron therapy in iran and fars province
topic Proton therapy
Carbon ion radiotherapy
Patient selection
Treatment costs
Hospitals
url http://ijms.sums.ac.ir/index.php/IJMS/article/view/4108
work_keys_str_mv AT mohammadaminhosseini apreliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadmohamadianpanah apreliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadzarebandeamiri apreliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadaminmoslehshirazi apreliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadaminhosseini preliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadmohamadianpanah preliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadzarebandeamiri preliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince
AT mohammadaminmoslehshirazi preliminarystudyontheestimationofthenumberofcancerpatientseligibleforhadrontherapyiniranandfarsprovince